Meta-analysis of randomized clinical trials comparing biodegradable polymer drug-eluting stent to second-generation durable polymer drug-eluting stents
Objectives: The authors sought to perform a meta-analysis of randomized clinical trials
(RCTs) comparing the safety and efficacy of biodegradable polymer drug-eluting stents (BP …
(RCTs) comparing the safety and efficacy of biodegradable polymer drug-eluting stents (BP …
Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice …
EP Navarese, K Tandjung, B Claessen, F Andreotti… - Bmj, 2013 - bmj.com
Objectives To investigate the safety and efficacy of durable polymer drug eluting stents
(DES) and biodegradable polymer biolimus eluting stents (biolimus-ES). Design Network …
(DES) and biodegradable polymer biolimus eluting stents (biolimus-ES). Design Network …
[HTML][HTML] Biodegradable polymer stents vs second generation drug eluting stents: a meta-analysis and systematic review of randomized controlled trials
AIM: To evaluate the premise, that biodegradable polymer drug eluting stents (BD-DES)
could improve clinical outcomes compared to second generation permanent polymer drug …
could improve clinical outcomes compared to second generation permanent polymer drug …
Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second-and third-generation drug-eluting stents
Background: Biodegradable polymer (BP) drug-eluting stents (DES) have been introduced
as a novel solution to the problems of durable polymer (DP) stents. In Pakistan, very few …
as a novel solution to the problems of durable polymer (DP) stents. In Pakistan, very few …
Assessment of utility values and QALYs after primary PCI with DP-Xience and BP-Biomatrix stents
Background Primary percutaneous coronary intervention (PPCI) is the recommended
treatment in ST elevated myocardial infarction (STEMI). The determination of Quality of life …
treatment in ST elevated myocardial infarction (STEMI). The determination of Quality of life …
Randomized comparison of everolimus-and zotarolimus-eluting coronary stents with biolimus-eluting stents in all-comer patients
Background: There is limited data comparing the Xience everolimus-eluting stent (EES) and
the Resolute zotarolimus-eluting stent (ZES) with the BioMatrix biolimus-eluting stent (BES) …
the Resolute zotarolimus-eluting stent (ZES) with the BioMatrix biolimus-eluting stent (BES) …
[HTML][HTML] Major ischaemic and bleeding risks following current drug-eluting stent implantation: Are there differences across current drug-eluting stent types in real life?
E Schapiro-Dufour, A Tricotel, MS Slama… - Archives of …, 2019 - Elsevier
Background Current drug-eluting stents (c-DESs) reduce the occurrence of ischaemic
events, but expose recipients to stent thrombosis and bleeding secondary to preventive …
events, but expose recipients to stent thrombosis and bleeding secondary to preventive …
[HTML][HTML] A review of the ultrathin orsiro biodegradable polymer drug-eluting stent in the treatment of coronary artery disease
JJ Wu, JAH Way, D Brieger - Heart International, 2019 - ncbi.nlm.nih.gov
Drug-eluting stents (DES) have revolutionised the treatment of coronary artery disease
(CAD) in patients undergoing percutaneous coronary intervention. In recent years, there has …
(CAD) in patients undergoing percutaneous coronary intervention. In recent years, there has …
Efficacy and safety of biodegradable polymer biolimus-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
Y Ye, H Xie, Y Zeng, X Zhao, Z Tian, S Zhang - PloS one, 2013 - journals.plos.org
Backgrounds Drug-eluting stents (DES) with biodegradable polymers have been developed
to address the risk of thrombosis associated with first-generation DES. We aimed to …
to address the risk of thrombosis associated with first-generation DES. We aimed to …
Safety and efficacy of degradable vs. permanent polymer drug-eluting stents: A meta-analysis of 18,395 patients from randomized trials
Y Wang, S Liu, Y Luo, F Wang, H Liu, L Li… - International journal of …, 2014 - Elsevier
Background Degradable polymer drug-eluting stents (DP-DES) represent a promising
strategy to improve the delayed healing and hypersensitive reaction in the vessel. However …
strategy to improve the delayed healing and hypersensitive reaction in the vessel. However …